Athira Pharma, Inc.

Historical 13F Holders

Symbol
ATHA
CUSIP
04746L104
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 04746L104 since 12/18/2024, largest first.

Filer % of Class Filed
Acorn Bioventures, L.P. 13G/A
6.2% 1/8/2026
Event 1/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Oliveira Steven Michael 13G/A
4.1% 10/10/2025
Event 10/1/2025
BML Investment Partners, L.P. 13G/A
0% 12/18/2025
Event 12/18/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 2 1.05 k $595
2025 Q2 52 17.6 M $5.30M
2025 Q1 55 17.6 M $5.00M
2024 Q4 58 17.9 M $10.5M
2024 Q3 60 16.1 M $7.20M
2024 Q2 66 22.2 M $58.9M
2024 Q1 76 21.8 M $59.7M
2023 Q4 66 22.0 M $53.3M
2023 Q3 71 21.4 M $43.3M
2023 Q2 78 21.9 M $64.6M
2023 Q1 84 23.8 M $59.5M
2022 Q4 95 26.3 M $80.5M
2022 Q3 100 24.0 M $72.0M
2022 Q2 106 22.2 M $68.3M
2022 Q1 114 26.3 M $381M
2021 Q4 110 30.2 M $393M
2021 Q3 95 24.9 M $234M
2021 Q2 90 28.2 M $288M
2021 Q1 70 29.8 M $547M
2020 Q4 72 21.5 M $734M
2020 Q3 55 21.7 M $395M